StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by Bully88on Jul 09, 2020 11:37am

111 Views

Post# 31245501

RE:So in other words

with the conservative price of $75 per test it would take them 13,333.33333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333....... tests to achieve their first Million dollars in revenue?

is that possible for q2? yes
is it likely to happen? no (IMO)

if at the end of june they were at 40k revenue from testing (already discussed in previous posts)

thats 533 tests completed or 17 per day

we would need them to do 12800 tests in june or 426.6666666666667 tests per day in june to achieve that

I will be extremely tickled to hear we are anything around 100 tests per day average by end of q2

Bullboard Posts

Calibre discovers significant gold in Newfoundland